An_DT
essential_JJ
role_NN
for_IN
NF-kappaB_NN
in_IN
human_JJ
CD34_NN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
bone_NN
marrow_NN
cell_NN
survival_NN
._.

The_DT
transcription_NN
factor_NN
,_,
NF-kappaB_NN
,_,
is_VBZ
important_JJ
for_IN
T-cell_NN
activation_NN
,_,
B-cell_NN
maturation_NN
,_,
and_CC
human_JJ
immunodeficiency_NN
virus_NN
transcription_NN
and_CC
plays_VBZ
a_DT
role_NN
in_IN
alternatively_RB
mediating_VBG
and_CC
protecting_VBG
against_IN
apoptosis_NN
in_IN
a_DT
variety_NN
of_IN
cell_NN
types_NNS
._.

However_RB
,_,
a_DT
role_NN
for_IN
NF-kappaB_NN
in_IN
human_JJ
CD34_NN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
bone_NN
marrow_NN
cells_NNS
has_VBZ
not_RB
been_VBN
described_VBN
._.

We_PRP
provide_VBP
evidence_NN
here_RB
that_IN
virtually_RB
all_DT
human_JJ
CD34_NN
-LRB-_-LRB-
+_JJ
-RRB-_-RRB-
bone_NN
marrow_NN
cells_NNS
express_VBP
NF-kappaB_NN
that_WDT
can_MD
be_VB
activated_VBN
by_IN
exposure_NN
to_TO
phorbol_NN
12-myristate_NN
13-acetate_NN
and_CC
a_DT
variety_NN
of_IN
cytokines_NNS
,_,
eg_NN
,_,
tumor_NN
necrosis_NN
factor_NN
alpha_NN
,_,
interleukin-3_NN
,_,
and_CC
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
._.

In_IN
addition_NN
,_,
we_PRP
demonstrate_VBP
that_IN
NF-kappaB_NN
may_MD
be_VB
required_VBN
for_IN
human_JJ
CD34_NN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
bone_NN
marrow_NN
cell_NN
clonogenic_JJ
function_NN
and_CC
survival_NN
._.

These_DT
results_NNS
offer_VBP
insight_NN
into_IN
a_DT
new_JJ
role_NN
for_IN
NF-kappaB_NN
in_IN
maintaining_VBG
survival_NN
and_CC
function_NN
in_IN
hematopoietic_JJ
stem_NN
and_CC
progenitor_NN
cells_NNS
and_CC
suggest_VBP
that_IN
proposed_JJ
strategies_NNS
involving_VBG
inhibition_NN
of_IN
NF-kappaB_NN
activation_NN
as_IN
an_DT
adjunct_NN
to_TO
cancer_NN
chemotherapy_NN
should_MD
be_VB
approached_VBN
with_IN
caution_NN
._.

